Ignite Creation Date:
2025-12-26 @ 12:14 PM
Ignite Modification Date:
2025-12-31 @ 9:37 PM
Study NCT ID:
NCT04551300
Status:
COMPLETED
Last Update Posted:
2022-10-18
First Post:
2020-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients
Sponsor:
Shanghai Alebund Pharmaceuticals Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-15
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-31
First Submit QC Date:
None
Study First Post Date:
2020-09-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-17
Last Update Post Date:
2022-10-18
Last Update Post Date Type:
ACTUAL